glp 1 agonists how do they work GLP-1 Medications: Everything You Need to Know Glucagon-like peptide 1 in health
Description
Yet, heterogeneity ( I 2 ) decreases significantly from 66.1% at 3 months to 0.0% at 12 months, meaning more consistency in study results over time
These side effects are usually mild to moderate and may decrease or go away entirely after a few days or weeks of treatment
Bacteria, yeast, and transgenic plants are currently employed as bioreactors to produce recombinant human GLP-1
Monitoring and follow-up: Regular follow-up during the first 3-6 months of therapy allows for symptom assessment, dose optimization, and early identification of complications
Your doctor may reduce doses of those medications when starting a GLP-1
